Dr. Youngchul Kim received his Ph.D in Statistics from Seoul National University. He is an Associate Member in the Department of Biostatistics and Bioinformatics at Moffitt Cancer Center. He has been developing pharmacogenomics and bioinformatics techniques such as CONCORD and PDXGEM for anti-cancer drug repositioning and personalized cancer treatment. His recent research has been focused on molecular cancer biomarker discovery, clinical trial design, and microbiome association study of bacteria and virus in cancer diagnosis and prognosis.